Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

NCT00004025 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: dendritic cell-gp100-MART-1 antigen vaccine

Sponsor

Genzyme, a Sanofi Company